
XAP044
CAS No. 196928-50-4
XAP044 ( —— )
产品货号. M27492 CAS No. 196928-50-4
XAP044 是一种 mGlu7 选择性拮抗剂,可抑制野生型小鼠脑切片中的外侧杏仁核长时程增强 (LTP),在 88 nm 处具有半最大阻断。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥640 | 有现货 |
![]() ![]() |
5MG | ¥932 | 有现货 |
![]() ![]() |
10MG | ¥1766 | 有现货 |
![]() ![]() |
25MG | ¥3151 | 有现货 |
![]() ![]() |
50MG | ¥4755 | 有现货 |
![]() ![]() |
100MG | ¥6796 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称XAP044
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述XAP044 是一种 mGlu7 选择性拮抗剂,可抑制野生型小鼠脑切片中的外侧杏仁核长时程增强 (LTP),在 88 nm 处具有半最大阻断。
-
产品描述XAP044 is a mGlu7-selective antagonist which inhibits lateral amygdala long term potentiation (LTP) in brain slices from wild type mice with a half-maximal blockade at 88 nm.(In Vitro):Previous study showed that in contrast to all previous mGlu7-selective drugs, XAP044 did not act through the seven-transmembrane region but rather via a binding pocket localized in mGlu7's extracellular Venus flytrap domain, a region identified for orthosteric agonist binding, which was suggested by the chimeric receptor studies in recombinant cell line assays .(In Vivo):In rodent behavioral paradigms, XAP044 demonstrated good brain exposure and wide spectrum anti-stress and antidepressant- and anxiolytic-like efficacy. In addition, XAP044 could reduce freezing during acquisition of Pavlovian fear and innate anxiety, which was consistent with the phenotypes of mGlu7-deficient mice. Moreover, XAP044 was able to inhibit lateral amygdala long term potentiation (LTP) in brain slices from wild type mice with a half-maximal blockade at 88 nm. It was alos found that there was no effect of XAP044 on LTP of mGlu7-deficient mice, suggesting that such pharmacological effect was mGlu7-dependent .
-
体外实验——
-
体内实验——
-
同义词——
-
通路Neuroscience
-
靶点GluR
-
受体TRPV1
-
研究领域——
-
适应症——
化学信息
-
CAS Number196928-50-4
-
分子量380.137
-
分子式C15H9IO4
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESOc1ccc2c(c1)occ(Oc1ccc(I)cc1)c2=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Alexander Stokes. Methods and compositions for prevention and treatment of cardiac hypertrophy. US10137123B2
产品手册




关联产品
-
Ginsenoside Ro
GinsenosideRo 具有 Ca2+ 拮抗抗血小板作用。
-
VU6012962
VU6012962 是一种口服生物可利用的 CNS 渗透性代谢型谷氨酸受体 7 (mGlu7; IC50: 347 nM) 负变构调节剂。
-
(RS)-3-Hydroxyphenyl...
(RS)-3-Hydroxypheniglycine 是一种 PI 连接的代谢型谷氨酸受体激动剂。